There’s a wave of new cancer drugs being developed, approved, and covered in China, many of them targeting genetic drivers of a patient’s tumor.
They’re the same types of drugs that have transformed the way cancer is now treated in American patients — and that have made U.S. drug makers billions.
About the Author Reprints
There shouldn’t be a problem, all they have to do is enlist the T.C.M practitioners, and Acupuncturists.